- Home
- BPTH vs LKCO Comparison
BPTH vs LKCO Comparison
Compare BPTH & LKCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPTH
- LKCO
- Stock Information
- Founded
- BPTH 2007
- LKCO 2009
- Country
- BPTH United States
- LKCO China
- Employees
- BPTH N/A
- LKCO N/A
- Industry
- BPTH Biotechnology: Pharmaceutical Preparations
- LKCO EDP Services
- Sector
- BPTH Health Care
- LKCO Technology
- Exchange
- BPTH Nasdaq
- LKCO Nasdaq
- Market Cap
- BPTH 4.8M
- LKCO 5.5M
- IPO Year
- BPTH N/A
- LKCO N/A
- Fundamental
- Price
- BPTH $0.73
- LKCO $1.89
- Analyst Decision
- BPTH Strong Buy
- LKCO
- Analyst Count
- BPTH 2
- LKCO 0
- Target Price
- BPTH $30.00
- LKCO N/A
- AVG Volume (30 Days)
- BPTH 161.7K
- LKCO 32.5K
- Earning Date
- BPTH 03-07-2025
- LKCO 10-22-2024
- Dividend Yield
- BPTH N/A
- LKCO N/A
- EPS Growth
- BPTH N/A
- LKCO N/A
- EPS
- BPTH N/A
- LKCO N/A
- Revenue
- BPTH N/A
- LKCO $5,389,818.00
- Revenue This Year
- BPTH N/A
- LKCO N/A
- Revenue Next Year
- BPTH N/A
- LKCO N/A
- P/E Ratio
- BPTH N/A
- LKCO N/A
- Revenue Growth
- BPTH N/A
- LKCO N/A
- 52 Week Low
- BPTH $0.59
- LKCO $1.43
- 52 Week High
- BPTH $10.00
- LKCO $8.00
- Technical
- Relative Strength Index (RSI)
- BPTH 37.30
- LKCO 49.53
- Support Level
- BPTH $0.78
- LKCO $1.75
- Resistance Level
- BPTH $0.84
- LKCO $1.99
- Average True Range (ATR)
- BPTH 0.05
- LKCO 0.20
- MACD
- BPTH -0.02
- LKCO -0.00
- Stochastic Oscillator
- BPTH 4.05
- LKCO 46.67
About BPTH Bio-Path Holdings Inc.
Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.
About LKCO Luokung Technology Corp
Luokung Technology Corp is a spatial-temporal intelligent big data services company, as well as a provider of LBS for various industries in China. It has established city-level and industry-level holographic spatial-temporal digital twin systems and actively serves industries including smart transportation (autonomous driving, smart highway and vehicle-road collaboration), natural resource asset management (carbon neutral and environmental protection remote sensing data service), and LBS smart industry applications (mobile Internet LBS, smart travel, smart logistics, new infrastructure, smart cities, emergency rescue, among others).